Small Numbers, Big Challenges: Adolescent and Young Adult Cancer Incidence and Survival in New Zealand
- PMID: 28207291
- DOI: 10.1089/jayao.2016.0074
Small Numbers, Big Challenges: Adolescent and Young Adult Cancer Incidence and Survival in New Zealand
Abstract
Purpose: This study was undertaken to determine cancer survival and describe the unique spectrum of cancers diagnosed among New Zealand's adolescents and young adult (AYA) population.
Methods: Registrations for 1606 15-24 year olds diagnosed with a new primary malignant tumor between 2000 and 2009 were obtained from the New Zealand Cancer Registry and classified according to AYA diagnostic group and subgroup, age, sex, and prioritized ethnicity. Age-standardized incidence rates (IRs) per million person years and 5-year relative survival ratios were calculated.
Results: Cancer incidence was 228.6 per million for adolescents aged 15-19 years and 325.7 per million for young adults aged 20-24 years. Overall IRs were consistent across all ethnic groups but there were unique ethnic differences by tumor group including a higher incidence of bone tumors, carcinoma of the gastrointestinal tract, and gonadal germ cell tumors among Maori, a higher incidence of leukemia among Pacific peoples, and a higher incidence of melanoma among non-Maori/non-Pacific peoples. Five-year relative survival for adolescents (75.1%) and AYA overall (80.6%) appeared poorer than had been achieved in other high-income countries. Maori (69.5%) and Pacific (71.3%) AYA had lower 5-year survival compared to non-Maori/non-Pacific peoples (84.2%).
Conclusion: The survival disparities observed require further investigation to identify and address the causes of these inferior outcomes. The newly established AYA Cancer Network Aotearoa has been tasked with improving cancer survival and care and ensuring equality of access for New Zealand AYAs with cancer.
Keywords: disparities; ethnicity; incidence; survival.
Similar articles
-
The burden of cancer in 25-29 year olds in New Zealand: a case for a wider adolescent and young adult age range?N Z Med J. 2018 Jan 19;131(1468):15-24. N Z Med J. 2018. PMID: 29346353
-
Obscure etiology, unusual disparity: the epidemiology of testicular cancer in New Zealand.Cancer Causes Control. 2015 Apr;26(4):561-9. doi: 10.1007/s10552-015-0533-4. Epub 2015 Feb 17. Cancer Causes Control. 2015. PMID: 25687480
-
Trends in Cancer Mortality Among Adolescents and Young Adults in Brazil.J Adolesc Young Adult Oncol. 2017 Jun;6(2):341-347. doi: 10.1089/jayao.2016.0042. Epub 2017 Jan 4. J Adolesc Young Adult Oncol. 2017. PMID: 28051344
-
The puzzling incidence of testicular cancer in New Zealand: what can we learn?Andrology. 2019 Jul;7(4):394-401. doi: 10.1111/andr.12584. Epub 2019 Jan 20. Andrology. 2019. PMID: 30663250 Review.
-
Ethnic disparity of pancreatic cancer in New Zealand.Int J Gastrointest Cancer. 2002;31(1-3):137-45. doi: 10.1385/IJGC:31:1-3:137. Int J Gastrointest Cancer. 2002. PMID: 12622425 Review.
Cited by
-
Prognostic factors for in-transit metastasis in patients with malignant melanoma.Med Pharm Rep. 2022 Jan;95(1):40-46. doi: 10.15386/mpr-2173. Epub 2022 Jan 31. Med Pharm Rep. 2022. PMID: 35720233 Free PMC article.
-
Whole-Body Magnetic Resonance Imaging (MRI) for Staging Melanoma Patients in Direct Comparison to Computed Tomography (CT): Results from a Prospective Positron Emission Tomography (PET)/CT and PET/MRI Study.Diagnostics (Basel). 2023 Jun 5;13(11):1963. doi: 10.3390/diagnostics13111963. Diagnostics (Basel). 2023. PMID: 37296815 Free PMC article.
-
Rapid disease progression on immune checkpoint inhibitors in young patients with stage IV melanoma.Front Med (Lausanne). 2023 Jan 23;10:1117816. doi: 10.3389/fmed.2023.1117816. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36756176 Free PMC article.
-
Childhood Cancer Survival in Brunei Darussalam.Asian Pac J Cancer Prev. 2020 Nov 1;21(11):3259-3266. doi: 10.31557/APJCP.2020.21.11.3259. Asian Pac J Cancer Prev. 2020. PMID: 33247683 Free PMC article.
-
Disparities in Testicular Cancer: A Review of the Literature.Cancers (Basel). 2024 Oct 10;16(20):3433. doi: 10.3390/cancers16203433. Cancers (Basel). 2024. PMID: 39456529 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources